The efficacy of amrubicin third‐line chemotherapy in patients with relapsed extensive‐disease small‐cell lung cancer: A retrospective and historical study in a single institute

BACKGROUND: The efficacy of amrubicin for relapsed small‐cell lung cancer (SCLC) has been reported in previous studies. Few reports, however, describe the efficacy and survival benefit of third‐line amrubicin chemotherapy in patients with extensive disease (ED)‐SCLC. METHODS: We retrospectively anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Sonehara, Kei, Tateishi, Kazunari, Fukushima, Toshirou, Komatsu, Masamichi, Yamamoto, Hiroshi, Koizumi, Tomonobu, Hanaoka, Masayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718015/
https://www.ncbi.nlm.nih.gov/pubmed/31350820
http://dx.doi.org/10.1111/1759-7714.13150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718015/
https://www.ncbi.nlm.nih.gov/pubmed/31350820
http://dx.doi.org/10.1111/1759-7714.13150

Ejemplares similares